TXG240816P17500
- 0.76
- -0.02-2.56%
10x Genomics Newsroom
Tesla Bull Cathie Wood's Ark Invest Sells $7.16M Worth Of EV Maker's Shares After Q2 Earnings Reveal Profits Tanked Sharply
Canaccord Genuity Adjusts Price Target on 10x Genomics to $32 From $50, Maintains Buy Rating
10x Genomics Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on 10x Genomics, Lowers Price Target to $32
CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Cuts Target Price to $32
Express News | 10X Genomics Inc : Canaccord Genuity Cuts Target Price to $32 From $50
10x Genomics Shares Rise Following Jefferies Upgrade
Top Premarket Gainers
Express News | 10x Genomics Shares Are Trading Higher After Jefferies Upgraded the Stock From Hold to Buy
Jefferies Upgrades 10x Genomics(TXG.US) to Buy Rating, Maintains Target Price $24
10x Genomics: A Strong Buy on Superior Technology and Promising Financial Trajectory
Express News | 10X Genomics Shares up 4.5% Premarket After Jefferies Raises to Buy From Hold
Express News | 10X Genomics Inc : Jefferies Raises to Buy From Hold
10x Genomics, Inc. (TXG): Hedge Funds Think This Stock Will Skyrocket
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
10x Genomics Shares Fall After JPMorgan Downgrade
Express News | 10x Genomics Shares Are Trading Lower After JP Morgan Downgraded the Stock From Overweight to Neutral and Lowered Its Price Target From $40 to $20
10x Genomics Is Maintained at Neutral by B of A Securities
10x Genomics Price Target Cut to $25.00/Share From $36.00 by B of A Securities
BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Cuts Target Price to $25